Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 5/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 5/20 | 0.37 |
| ▸ | MAOB | P27338 | 4/20 | 0.37 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | KDM5A | P29375 | 1/20 | 0.36 |
| ▸ | KDM5C | P41229 | 1/20 | 0.36 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.36 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | PDE9A | O76083 | 2/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17570608 | 0.92 | MAOA (0.49) | ELANECYP11B2MAOAMAOBNCOA3 | |
| SCHEMBL17570642 | 0.85 | KDM5A (0.40) | ELANECYP11B2MAOANCOA3KDM5A | |
| SCHEMBL17570523 | 0.83 | DDB1 (0.40) | ELANECYP11B2MAOAMAOBNCOA3 | |
| SCHEMBL16127461 | 0.82 | CYP11B2 (0.46) | ELANECYP11B2MAOAMAOBNCOA3 | |
| SCHEMBL23983292 | 0.78 | CYP11B2 (0.41) | CYP11B2MAOAMAOBNCOA3ACHE | |
| SCHEMBL23984106 | 0.78 | CYP11B2 (0.41) | CYP11B2MAOAMAOBNCOA3ACHE | |
| SCHEMBL31272939 | 0.78 | CYP11B2 (0.41) | CYP11B2MAOAMAOBNCOA3ACHE | |
| SCHEMBL31273354 | 0.76 | CYP11B2 (0.50) | CYP11B2MAOAMAOBACHEPDE10A | |
| SCHEMBL16127254 | 0.76 | PDE10A (0.38) | CYP11B2MAOANCOA3PDE10ACYP11B1 | |
| SCHEMBL17570560 | 0.76 | NCOA3 (0.40) | ELANEMAOAMAOBNCOA3ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3375785-B1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2020-08-05 | — | — | EP | disclosed |
| US-10193079-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2019-01-29 | — | — | US | disclosed |
| EP-2976329-B1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2018-06-27 | — | — | EP | disclosed |
| US-20160072076-A1 | MATERIALS FOR ELECTRONIC DEVICES | UDC IRELAND LIMITED (IE) | 2016-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160072076-A1 | MATERIALS FOR ELECTRONIC DEVICES | AOC3, AOC2, AOC1 | ELANE 232/4885CYP11B2 395/4885MAOA 34/4885 |
| US-10193079-B2 | Materials for electronic devices | AOC3, AOC2, AOC1 | ELANE 232/4885CYP11B2 395/4885MAOA 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.